In Silico Trials integrate artificial intelligence, machine learning algorithms, and physics-based mechanistic modeling to dynamically predict long-term clinical endpoints and unexpected side effects.
The in silico trials market size is expected to reach US$ 12.75 billion by 2034 from US$ 4.64 billion in 2025. The market is anticipated to register a CAGR of 11.9% during 2026–2034.
What...